HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 26, Pages 5879
Publisher
Baishideng Publishing Group Inc.
Online
2016-07-26
DOI
10.3748/wjg.v22.i26.5879
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
- (2016) Sook Ryun Park et al. EUROPEAN JOURNAL OF CANCER
- Heterogeneous Her2/Neu expression in gastric and gastroesophageal cancer
- (2016) Federica Grillo et al. HUMAN PATHOLOGY
- Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
- (2016) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
- (2015) Phillip Stahl et al. BMC GASTROENTEROLOGY
- Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections
- (2015) Federica Grillo et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks
- (2015) Xiaowen Ge et al. HUMAN PATHOLOGY
- HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases
- (2015) Rocco Cappellesso et al. HUMAN PATHOLOGY
- Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens
- (2015) Sangjeong Ahn et al. Oncotarget
- Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization
- (2014) Yoriko Yamashita-Kashima et al. Gastric Cancer
- HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
- (2014) Eric Van Cutsem et al. Gastric Cancer
- Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status
- (2014) Tao Wang et al. HUMAN PATHOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma
- (2014) Hiroshi Yoshida et al. VIRCHOWS ARCHIV
- Clinical management of advanced gastric cancer: The role of new molecular drugs
- (2014) Ferdinando De Vita WORLD JOURNAL OF GASTROENTEROLOGY
- Reproducibility of Her2/neu scoring in gastric cancer and assessment of the 10% cut-off rule
- (2014) Hans-Michael Behrens et al. Cancer Medicine
- Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study
- (2013) S. Watson et al. ANNALS OF ONCOLOGY
- The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis
- (2013) Matteo Fassan et al. HUMAN PATHOLOGY
- Level ofHER2Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab
- (2013) Carlos Gomez-Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions
- (2013) Nicola Fusco et al. MODERN PATHOLOGY
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
- (2012) V. S. Warneke et al. ANNALS OF ONCOLOGY
- Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
- (2012) H. H. Yoon et al. CLINICAL CANCER RESEARCH
- Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
- (2012) Hee Eun Lee et al. EUROPEAN JOURNAL OF CANCER
- A global assessment of the oesophageal adenocarcinoma epidemic
- (2012) Gustaf Edgren et al. GUT
- Early HER2 dysregulation in gastric and oesophageal carcinogenesis
- (2012) Matteo Fassan et al. HISTOPATHOLOGY
- Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer
- (2012) Sofia Asioli et al. HUMAN PATHOLOGY
- Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas
- (2012) Matteo Fassan et al. HUMAN PATHOLOGY
- Delay to formalin fixation ‘cold ischemia time’: effect on ERBB2 detection by in-situ hybridization and immunohistochemistry
- (2012) Bryce P Portier et al. MODERN PATHOLOGY
- Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas
- (2012) Eun Yoon Cho et al. MODERN PATHOLOGY
- HER2 testing in gastric cancer: a practical approach
- (2012) Josef Rüschoff et al. MODERN PATHOLOGY
- Effect of Ischemic Time, Fixation Time, and Fixative Type on HER2/neu Immunohistochemical and Fluorescence In Situ Hybridization Results in Breast Cancer
- (2011) Neda A. Moatamed et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Evaluation of HER2 Protein Expression in Gastric Carcinomas: Comparative Analysis of 1414 Cases of Whole-Tissue Sections and 595 Cases of Tissue Microarrays
- (2011) Kab Choong Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma
- (2011) C Bozzetti et al. BRITISH JOURNAL OF CANCER
- Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens
- (2011) Jiyuan Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Molecular Classification of Gastric Cancer: A New Paradigm
- (2011) M. A. Shah et al. CLINICAL CANCER RESEARCH
- Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections*
- (2011) Stephen Lee et al. HISTOPATHOLOGY
- Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma
- (2011) Min A Kim et al. HISTOPATHOLOGY
- Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
- (2011) Maria D. Begnami et al. JOURNAL OF CLINICAL ONCOLOGY
- Dual-colour HER2/Chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples
- (2011) B. Yan et al. JOURNAL OF CLINICAL PATHOLOGY
- HER2 status in unusual histological variants of gastric adenocarcinomas
- (2011) Giuseppe Giuffrè et al. JOURNAL OF CLINICAL PATHOLOGY
- HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma
- (2011) Yingchuan Hu et al. MODERN PATHOLOGY
- Pathology of Gastric Intestinal Metaplasia: Clinical Implications
- (2010) Pelayo Correa et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Micropapillary Carcinoma of Stomach
- (2010) Ji Hyeon Roh et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
- (2010) Elisa Rossi et al. HISTOPATHOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material
- (2010) Anuttara Panchali Kumarasinghe et al. PATHOLOGY
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
- (2010) Josef Rüschoff et al. VIRCHOWS ARCHIV
- Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
- (2009) J D Barros-Silva et al. BRITISH JOURNAL OF CANCER
- HER-2 amplification is highly homogenous in gastric cancer
- (2009) Andreas H. Marx et al. HUMAN PATHOLOGY
- HER-2 amplification is highly homogenous in gastric cancer
- (2009) Michael Bilous et al. HUMAN PATHOLOGY
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
- (2009) Guido Sauter et al. JOURNAL OF CLINICAL ONCOLOGY
- Delay to formalin fixation effect on breast biomarkers
- (2009) Thaer Khoury et al. MODERN PATHOLOGY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- HER-2 overexpression/amplification in Barrett’s oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study
- (2008) Elisa Rossi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started